Gender Male
During 10 years employment as a physicist during which Amrania spear-headed the research and development of Digistain as cancer diagnostic device from its infancy in the lab, through designing and conducting clinical trials to commissioning a prototype in a cancer hospital whilst filing two diagnostic technology patents along the way.
He teamed up
with the vice president of Johnson & Johnson to interview industry leaders and experts to commercially validate Digistain. He then pitched the business case to heads of multinational companies including Phillips Medical and secured £250k funding for the project. Navigating the complex regulatory landscape surrounding the manufacture of medical devices he engineered and produced a beta prototype for market validation. He is now heading a multi-centre trial with cancer hospitals across the UK.
